Pain Management in Osteoarthritis and Sciatica After a Severe NSAID‑Induced Upper GI Bleed

Medication Reconciliation

Oral NSAIDs (including meloxicam) must be discontinued because the American College of Rheumatology (ACR) issues a strong recommendation against any oral NSAID in patients who have experienced an upper GI bleed within the past year, even when proton‑pump inhibitor (PPI) therapy is used. [4][5]2
Continue dual gastro‑protective therapy (PPI + sucralfate) for ulcer healing; this regimen does not mitigate the risk of NSAID‑related bleeding. [4][5]

Prescribe acetaminophen 1000 mg three times daily (≈3 g/day) as the preferred baseline analgesic for osteoarthritis in older adults with high GI risk; this dose stays below the FDA maximum of 4 g/day and is considered moderately recommended for safety. [1][6]7
Screen for hidden acetaminophen sources (e.g., codeine‑guaifenesin preparations) to avoid inadvertent overdose. [4][3]

Continue duloxetine 60 mg daily; the ACR provides a conditional recommendation for duloxetine in patients with osteoarthritis who cannot use NSAIDs or have failed other therapies, citing efficacy for both knee OA and neuropathic pain such as sciatica. [4][2]3
The 2022 CDC guideline notes that duloxetine shows greater effectiveness in patients > 65 years with osteoarthritis. 1
Monitor for nausea and sedation, common adverse effects that usually improve with continued therapy. 1

Use oxycodone 5 mg every 8–12 hours PRN for breakthrough pain; the ACR issues a strong recommendation for short‑term opioid use when patients have inadequate response to safer modalities and contraindications to NSAIDs. [2][3]
Limit the prescription to 2–4 weeks with defined reassessment points, aligning with CDC guidance for time‑limited opioid therapy. [1][9]

Consider tramadol 25–50 mg every 6–8 hours PRN; the ACR gives a conditional recommendation for tramadol over non‑tramadol opioids when an opioid is contemplated. [4][10][3][7]
Watch for serotonin syndrome due to the interaction between tramadol (a serotonin reuptake inhibitor) and duloxetine; start at the lowest dose (25 mg). 10
Tramadol carries a lower risk of respiratory depression but a dose‑related seizure risk, especially at higher doses. 10

Maintain gabapentin 600 mg three times daily (≈1800 mg/day) for sciatica‑related neuropathic pain; CDC data show small but clinically meaningful improvements with this regimen, though sedation and cognitive effects are common. [1][6]
Dose titration above 1800 mg/day is generally avoided in older adults because of tolerability concerns. 6

All oral NSAIDs, including COX‑2 inhibitors (e.g., celecoxib), are contraindicated after a recent severe GI bleed. [4][5][2][8]
Topical NSAIDs should also be avoided in the immediate post‑bleed period, as ACR recommendations for topical use apply only to patients ≥ 75 years without recent severe GI events. [4][3]
Glucosamine/chondroitin supplements are conditionally recommended against by the ACR. [4][5]
Topical capsaicin is conditionally recommended against for osteoarthritis by the ACR. [4][5]

Lidocaine 5 % patches are endorsed by the American Geriatrics Society (strong recommendation) for localized neuropathic pain and should be continued. [1][8]
Physical‑therapy programs adapted for wheelchair users, transcutaneous electrical nerve stimulation (TENS), and local heat/cold therapy are supported by evidence for functional improvement in osteoarthritis. [11][12]

Reassess pain control every 2–4 weeks and begin tapering oxycodone as duloxetine reaches its full effect (typically 4–6 weeks). [1][7]
Monitor for opioid‑related adverse events (constipation, sedation, increased fall risk) given the patient’s mobility limitations. [1][8]
Renal function should be checked regularly because of concurrent furosemide use and the need to avoid NSAIDs that could mask renal decline. [4][8]
Hepatic function monitoring is advised for acetaminophen at 3 g/day, especially in the context of polypharmacy. [6][8]
Prevent opioid‑induced constipation by adding a stimulant laxative (e.g., senna) to the existing linaclotide regimen. [1][8]